https://www.thebodypro.com/author/terri-wilder
Terri Wilder, M.S.W.

Terri Wilder, M.S.W.

Terri L. Wilder, M.S.W., has been part of the HIV community since 1989, and has been a reporter and writer for TheBody/TheBodyPro since 2007. She served on the New York Governor's Task Force to End AIDS, was recognized by POZ magazine for her work in HIV, and is highlighted in the book Fag Hags, Divas and Moms: The Legacy of Straight Women in the AIDS Community by Victoria Noe. She loves this community and will keep fighting until the epidemic is over.

Latest by Terri Wilder, M.S.W.

Marlon M. Bailey and Tonia Poteat
Interviews

LGBTQ Health and Well-Being: Where Is the U.S. Right Now?

Tonia Poteat, Ph.D., PA-C, M.P.H., and Marlon M. Bailey, Ph.D., dive into the important takeaways of a major new report on sexual and gender diverse populations in the U.S.

By Terri Wilder, M.S.W.
pain
Interviews

How Can We Manage Pain Better in Older Adults Living With HIV?

“Telling them now that ‘the government is saying I need to decrease your opioids. ... Sorry you’re going to suffer,’ was just not satisfying to me as a physician,” says Maile Young Karris, M.D.

By Terri Wilder, M.S.W.
groceries
Conference Coverage

HIV Incidence Is Lower in States With More Generous Low-Income Food Benefits

“The message that needs to be communicated to people in power, and it needs to be communicated loud and frequently, is, ‘Look. Here’s the actual human cost of not enacting these kinds of policies. Here’s the potential benefit,’” says Aaron Richterman, M.D., M.P.H.

By Terri Wilder, M.S.W.
Biden Harris
Interviews

Will the Biden-Harris Administration Breathe Life Back Into Vital HIV and Hepatitis Programs?

We spoke with Amy Killelea at NASTAD, a major national health policy advocacy organization, about the priorities she sees in January 2021 and beyond.

By Terri Wilder, M.S.W.
birds on soil
Interviews

Histoplasmosis and HIV in the U.S.: Often Forgotten, Never Gone

IDWeek 2020 provided a perfect opportunity to better understand the modern-day impact of histoplasmosis among Americans living with HIV—and to bone up on the basics.

By Terri Wilder, M.S.W.
doctor talking to unrecognizable patient
Conference Coverage

For PrEP to Work, Shared Doctor-Patient Decision-Making Is Key

The process of choosing between PrEP options is often not straightforward. Oni Blackstock, M.D., explains how providers can help ensure their patients end up with the most successful option for them.

By Terri Wilder, M.S.W.
HIV and COVID-19-iStock-1216628411
Interviews

HIV Clinicians Have Played a Key Role in U.S. COVID-19 Treatment Guidelines. We Spoke With One of Them.

COVID-19 Treatment Guidelines Panel member Arthur Kim, M.D., discusses the guidelines and the experience of treating COVID-19 from an HIV care provider’s perspective.

By Terri Wilder, M.S.W.
intimate
Interviews

Understanding U=U Can Improve Health Outcomes for People Living with HIV—but the Message Matters

W. David Hardy, M.D., discusses the takeaway messages for HIV care providers after a recent research paper found that a third of all people living with HIV reported never discussing U=U with their provider.

By Terri Wilder, M.S.W.
smoking
Interviews

Smoking Rates Are Higher in the LGBTQ Community; Can More Inclusive Data Help?

Scout, Ph.D., the head of the National LGBT Cancer Network, lays out the current state of the interplay between nicotine, cancer, HIV, and people who are LGBTQ.

By Terri Wilder, M.S.W.
monoclonal antibodies
Interviews

Are Monoclonal Antibodies the Future of COVID-19 Treatment?

Infectious-diseases researcher David Wohl, M.D., talks about a major COVID-19 treatment trial in the works—and how it relates to our efforts against HIV.

By Terri Wilder, M.S.W.